{"id":"W4378978155","doi":"10.1016/j.msard.2023.104786","title":"Beyond the B-cell as a treatment target in multiple sclerosis","year":2023,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"SickKids Foundation; University of Toronto","funders":"","keywords":"Ocrelizumab; Medicine; Multiple sclerosis; Ofatumumab; Internal medicine; Natalizumab; Dermatology; CD20; Rituximab; Immunology; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.001105479,0.001402318,0.001973203,0.0008384777,0.001013558,0.0002402873,0.0005907568,0.001976101,0.000205489],"category_scores_gemma":[0.005079564,0.00094289,0.0008317916,0.001541672,0.001052799,0.0001868603,0.00063779,0.002549349,0.0005360275],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007441238,"about_ca_system_score_gemma":0.0005811595,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008721777,"about_ca_topic_score_gemma":0.005457827,"domain_scores_codex":[0.9923893,0.0004097862,0.001448827,0.001967632,0.001962814,0.001821631],"domain_scores_gemma":[0.9915586,0.005680714,0.000478952,0.00135303,0.0003250103,0.0006036556],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001362401,0.002246503,0.01764473,0.0005479408,0.001490359,0.0000477932,0.003954079,0.000341391,0.003078385,0.000005660333,0.9435595,0.02572132],"study_design_scores_gemma":[0.05796708,0.002875156,0.09685921,0.003226018,0.001079275,0.000003989338,0.005101892,0.007686784,0.0008508968,0.0003137608,0.8215487,0.002487262],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"empirical","genre_scores_codex":[0.1864955,0.02953666,0.000007296004,0.009045452,0.7511647,0.01129171,0.002165726,0.001233942,0.009059086],"genre_scores_gemma":[0.4945002,0.3808934,0.00040655,0.0002190902,0.1023307,0.003555957,0.003350718,0.0009462124,0.0137972],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.6488339,"threshold_uncertainty_score":0.9998727,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03763177313008521,"score_gpt":0.2723908189235822,"score_spread":0.234759045793497,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}